Robotic radiation can reduce number of shots needed to treat wet AMD, study reveals
By
Kristen Fischer
Jun 13, 2024
Robot-guided radiation therapy can be an effective treatment for age-related macular degeneration (AMD), according to a study published Tuesday in The Lancet.
Daily aspirin doesn’t stop AMD from developing, getting worse: study
By
Kristen Fischer
May 23, 2024
A new study finds that taking low-dose aspirin over the long term didn’t affect the progression of age-related macular degeneration, or AMD, or stop the risk for it altogether.
Report: Age-related eye diseases raise risk for falls, fractures
By
Kristen Fischer
Jan 02, 2024
Older adults who have cataract, age-related macular degeneration (AMD) or glaucoma are at a higher risk for falls and fractures, according to a new study. Glaucoma raises an individual’s risk for taking...
Roche’s eye implant may reduce vision loss treatment time for seniors
By
Alicia Lasek
Oct 26, 2021
The FDA has approved an ocular implant that could reduce the treatment schedule from monthly to twice yearly for older adults with “wet” macular degeneration.
First biosimilar approved by FDA to treat common eye degeneration in elders
By
Alicia Lasek
Sep 21, 2021
The Food and Drug Administration has approved a less expensive copy of the blockbuster drug Lucentis for treating age-related (wet) macular degeneration and several other eye conditions.
Eye drop corrects late-life vision loss in trial; Allergan reports patients’ feedback
By
Alicia Lasek
May 10, 2021
Trial participants reported significant near-vision improvements under low-light conditions — without losing distance vision, reports Allergan, which is seeking FDA approval for the drug.
20-year glaucoma follow-up finds vision loss in only one fourth of patients
By
Alicia Lasek
Apr 21, 2021
Ocular hypertension led to glaucoma in about half of patients over two decades, and to at least some vision loss in 25%. The findings may help clinicians and patients make personalized choices about managing...
No more reading glasses? Eye drop for seniors’ vision loss lands on FDA’s desk
By
Alicia Lasek
Mar 09, 2021
Drugmaker Allergan is seeking federal approval for a new eye drop that treats presbyopia, the common age-related vision loss that often prompts a need for reading glasses.
Metformin may prevent a common cause of vision loss in aging
By
Alicia Lasek
Feb 01, 2021
The diabetes drug metformin may protect against age-related macular degeneration, a potentially blinding condition for which there appears to be no effective preventive measures, researchers contend.
Clinical briefs for Monday, Sept. 14
By
Kimberly Marselas
Sep 13, 2020
Failure to thrive: Study reveals home health services often go undelivered … Chronic microaspiration could be hidden frailty factor, case studies suggest … Good cardiovascular health linked to lower...